Drug intelligence / Profile preview

grass and rye pollens allergoids

Development stage
Unknown
Lead developer
ALK Abelló
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous, Sublingual
01

Overview

Grass and rye pollens allergoids are chemically modified allergen extracts used in allergen-specific immunotherapy (AIT) to treat allergic rhinitis and rhinoconjunctivitis caused by grass and rye pollen. These allergoids are designed to have reduced allergenicity (lower IgE-binding capacity) but retained immunogenicity (ability to stimulate an immune response), which allows for the administration of higher, more effective doses with an improved safety profile. The mechanism of action involves modulating the immune system to induce tolerance to the specific pollen allergens. This is achieved by shifting the T-helper cell balance from a Th2-dominant (allergic) to a Th1-dominant (non-allergic) response, promoting the generation of regulatory T cells, and increasing the production of allergen-specific IgG antibodies that can block IgE-mediated reactions. This leads to a sustained reduction in allergic symptoms upon subsequent natural exposure to grass and rye pollens.

Brand names
OralairAllergovitPollinex QuatroCLUSTOID
Other names
Allergenic extracts, grass pollenStandardized Grass Pollen Allergenic ExtractsMixed grass pollens allergen extract
02

Targets

Phl p (Timothy grass pollen allergen)

Beyond the preview

Go deeper on grass and rye pollens allergoids.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on grass and rye pollens allergoids.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call